Global Chronic Aspergillosis Treatment Market to Surpass US$ 4,056.4 Million by 2028, Says Coherent Market Insights (CMI) SEATTLE, Sept. 09, 2021 (GLOBE NEWSWIRE) -- According to Coherent Market Insights, the global chronic aspergillosis treatment market is estimated to be valued at US$ 2,916.3 million in 2021 and is...

Pulmocide Raises $92 million in a Series C Financing to Fund Registration Program for PC945 Pulmocide Raises $92 million in a Series C Financing to Fund Registration Program for PC945 London, UK, 27 May 2021 – Pulmocide Ltd., (“the Company”) a late-stage biopharmaceutical company...

Jeito Capital leads oversubscribed $92 million Series C financing round in Pulmocide Jeito Capital leads oversubscribed $92 million Series C financing round in Pulmocide Jeito selects Pulmocide as its fourth investment since launching the fundPulmocide is a late-stage biopharma...

Pulmocide Raises $92 million in a Series C Financing to Fund Registration Program for PC945 Pulmocide Raises $92 million in a Series C Financing to Fund Registration Program for PC945 London, UK, 27 May 2021 – Pulmocide Ltd., (“the Company”) a late-stage biopharmaceutical company...